{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:29:04Z","timestamp":1781335744535,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02166-1","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:49:20Z","timestamp":1760701760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Circulating CGRP as a diagnostic biomarker in female migraine patients: a single-center case-control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Qinyue","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MeiJie","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaochu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"8","key":"2166_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17(8):501\u2013514","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2166_CR2","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.1503\/cmaj.211969","volume":"195","author":"V Tzankova","year":"2023","unstructured":"Tzankova V, Becker WJ, Chan TLH (2023) Diagnosis and acute management of migraine. CMAJ 195(4):E153\u2013E8","journal-title":"CMAJ"},{"issue":"6","key":"2166_CR3","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.3390\/ijms24065334","volume":"24","author":"C Demartini","year":"2023","unstructured":"Demartini C, Francavilla M, Zanaboni AM (2023) Biomarkers of migraine: an integrated evaluation of preclinical and clinical findings. Int J Mol Sci 24(6):5334","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2166_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02023-1","volume":"26","author":"O Grodzka","year":"2025","unstructured":"Grodzka O, \u0141agowski W, Eyileten C et al (2025) Biomarkers in headaches as a potential solution to simplify differential diagnosis of primary headache disorders: a systematic review. J Headache Pain 26(1):73","journal-title":"J Headache Pain"},{"issue":"1","key":"2166_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01769-4","volume":"25","author":"G G\u00e1rate","year":"2024","unstructured":"G\u00e1rate G, Pascual J, Pascual-Mato M et al (2024) Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience. J Headache Pain 25(1):69","journal-title":"J Headache Pain"},{"issue":"1","key":"2166_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0927-2","volume":"19","author":"CE Christensen","year":"2018","unstructured":"Christensen CE, Younis S, Deen M et al (2018) Migraine induction with calcitonin gene-related peptide in patients from erenumab trials. J Headache Pain 19(1):105","journal-title":"J Headache Pain"},{"issue":"1","key":"2166_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01189-0","volume":"21","author":"R Greco","year":"2020","unstructured":"Greco R, De Icco R, Demartini C (2020) Plasma levels of CGRP and expression of specific MicroRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine? J Headache Pain 21(1):122","journal-title":"J Headache Pain"},{"issue":"14","key":"2166_CR8","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","volume":"81","author":"E Cernuda-Moroll\u00f3n","year":"2013","unstructured":"Cernuda-Moroll\u00f3n E, Larrosa D, Ram\u00f3n C (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81(14):1191\u20131196","journal-title":"Neurology"},{"issue":"10483","key":"2166_CR9","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(25)00109-6","volume":"405","author":"J Versijpt","year":"2025","unstructured":"Versijpt J, Paemeleire K, Reuter U (2025) Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives. Lancet 405(10483):1014\u20131026","journal-title":"Lancet"},{"issue":"4","key":"2166_CR10","doi-asserted-by":"publisher","first-page":"333102424130538","DOI":"10.1177\/03331024241305381","volume":"45","author":"R Ornello","year":"2025","unstructured":"Ornello R, Caponnetto V, Ahmed F et al (2025) Evidence-based guidelines for the Pharmacological treatment of migraine [J]. Cephalalgia: Int J Headache 45(4):3331024241305381","journal-title":"Cephalalgia: Int J Headache"},{"key":"2166_CR11","unstructured":"IHS(2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition [J]. Cephalalgia: an International Journal of Headache 38(1)"},{"issue":"Suppl 3","key":"2166_CR12","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.1007\/s10072-004-0301-9","volume":"25","author":"AM Rapoport","year":"2004","unstructured":"Rapoport AM, Bigal ME (2004) ID-migraine. Neurol Sci 25(Suppl 3):S258\u2013S60","journal-title":"Neurol Sci"},{"issue":"4","key":"2166_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.37.4.378","volume":"37","author":"WW Downie","year":"1978","unstructured":"Downie WW, Leatham PA, Rhind VM et al (1978) Studies with pain rating scales [J]. Ann Rheum Dis 37(4):378\u2013381","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2166_CR14","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1097\/j.pain.0000000000000702","volume":"157","author":"S Guo","year":"2016","unstructured":"Guo S, Vollesen ALH, Olesen J et al (2016) Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine. Pain 157(12):2773\u20132781","journal-title":"Pain"},{"issue":"10283","key":"2166_CR15","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Terwindt GM, Al-Karagholi MA-M et al (2021) Migraine: disease characterisation, biomarkers, and precision medicine [J]. Lancet 397(10283):1496\u20131504","journal-title":"Lancet"},{"issue":"10200","key":"2166_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","volume":"394","author":"R Croop","year":"2019","unstructured":"Croop R, Goadsby PJ, Stock DA et al (2019) Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet 394(10200):737\u2013745","journal-title":"Lancet"},{"issue":"6","key":"2166_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1474-4422(23)00126-6","volume":"22","author":"S Yu","year":"2023","unstructured":"Yu S, Kim B-K, Guo A et al (2023) Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial [J]. Lancet Neurol 22(6):476\u2013484","journal-title":"Lancet Neurol"},{"issue":"9","key":"2166_CR18","doi-asserted-by":"publisher","first-page":"7125","DOI":"10.1007\/s11033-020-05781-0","volume":"47","author":"S P\u00e9rez-Pereda","year":"2020","unstructured":"P\u00e9rez-Pereda S, Toriello-Su\u00e1rez M, Ocejo-Vinyals G (2020) Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice. Mol Biol Rep 47(9):7125\u20137138","journal-title":"Mol Biol Rep"},{"issue":"34","key":"2166_CR19","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.2174\/0929867325666180622122938","volume":"26","author":"P Ferroni","year":"2019","unstructured":"Ferroni P, Barbanti P, Spila A et al (2019) Circulating biomarkers in migraine: new opportunities for precision medicine. Curr Med Chem 26(34):6191\u20136206","journal-title":"Curr Med Chem"},{"issue":"6","key":"2166_CR20","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/head.13802","volume":"60","author":"SD Frederiksen","year":"2020","unstructured":"Frederiksen SD, Bekker-Nielsen Dunbar M, Snoer AH (2020) Serotonin and neuropeptides in blood from episodic and chronic migraine and cluster headache patients in case-control and case-crossover settings: a systematic review and meta-analysis. Headache 60(6):1132\u20131164","journal-title":"Headache"},{"issue":"6","key":"2166_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K et al (2018) CGRP as the target of new migraine therapies - successful translation from bench to clinic [J]. Nat Rev Neurol 14(6):338\u2013350","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2166_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/14728222.2020.1724285","volume":"24","author":"A-S Wattiez","year":"2020","unstructured":"Wattiez A-S, Sowers LP, Russo AF (2020) Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets 24(2):91\u2013100","journal-title":"Expert Opin Ther Targets"},{"key":"2166_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-pharmtox-010814-124701","volume":"55","author":"AF Russo","year":"2015","unstructured":"Russo AF (2015) Calcitonin gene-related peptide (CGRP): a new target for migraine [J]. Annu Rev Pharmacol Toxicol 55:533\u2013552","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2166_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117043","volume":"282","author":"Y Qi","year":"2025","unstructured":"Qi Y, Gong H, Shen Z et al (2025) TRPM8 and TRPA1 ideal targets for treating cold-induced pain. Eur J Med Chem 282:117043","journal-title":"Eur J Med Chem"},{"issue":"11","key":"2166_CR25","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1021\/cn500083e","volume":"5","author":"G Dussor","year":"2014","unstructured":"Dussor G, Yan J, Xie JY et al (2014) Targeting TRP channels for novel migraine therapeutics [J]. ACS Chem Neurosci 5(11):1085\u20131096","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"2166_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrgastro.2016.76","volume":"13","author":"RA Travagli","year":"2016","unstructured":"Travagli RA, Anselmi L (2016) Vagal neurocircuitry and its influence on gastric motility. Nat Rev Gastroenterol Hepatol 13(7):389\u2013401","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2166_CR27","doi-asserted-by":"publisher","first-page":"543485","DOI":"10.3389\/fneur.2020.543485","volume":"11","author":"K Liu","year":"2020","unstructured":"Liu K, Wang BZ, Hao Y et al (2020) The correlation between migraine and patent foramen ovale [J]. Front Neurol 11:543485","journal-title":"Front Neurol"},{"issue":"9","key":"2166_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/01616412.2020.1775015","volume":"42","author":"F Khasiyev","year":"2020","unstructured":"Khasiyev F, Arsava EM, Topcuoglu MA (2020) Cerebral vasomotor reactivity in migraine: effect of patent foramen ovale and aerogenic microembolism. Neurol Res 42(9):795\u2013804","journal-title":"Neurol Res"},{"issue":"5","key":"2166_CR29","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1007\/s12325-025-03166-y","volume":"42","author":"L Pellesi","year":"2025","unstructured":"Pellesi L, Chalmer MA, Guo S et al (2025) Targeting PACAP: beyond migraine to cluster, menstrual, and post-traumatic headaches. Adv Ther 42(5):2078\u20132088","journal-title":"Adv Ther"},{"issue":"1","key":"2166_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/14728214.2024.2317778","volume":"29","author":"L Pellesi","year":"2024","unstructured":"Pellesi L, Ashina M, Martelletti P (2024) Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention. Expert Opin Emerg Drugs 29(1):57\u201364","journal-title":"Expert Opin Emerg Drugs"},{"issue":"2","key":"2166_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M et al (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622","journal-title":"Physiol Rev"},{"issue":"2","key":"2166_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","volume":"6","author":"JP Herman","year":"2016","unstructured":"Herman JP, McKlveen JM, Ghosal S et al (2016) Regulation of the Hypothalamic-Pituitary-Adrenocortical stress response [J]. Compr Physiol 6(2):603\u2013621","journal-title":"Compr Physiol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02166-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:49:23Z","timestamp":1760701763000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-02166-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2166"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02166-1","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from Medical Ethics Committee of Nanjing Drum Tower Hospital (Approval No. 2024-229-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors authorize the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}